Literature DB >> 24321235

Inappropriate subcutaneous implantable cardioverter-defibrillator shocks due to T-wave oversensing can be prevented: implications for management.

Kirsten M Kooiman1, Reinoud E Knops1, Louise Olde Nordkamp1, Arthur A M Wilde1, Joris R de Groot2.   

Abstract

BACKGROUND: Inappropriate shocks (IASs) complicate implantable cardioverter-defibrillator (ICD) therapy. The management of IASs in patients with a subcutaneous ICD (S-ICD) differs from that in patients with a conventional ICD because of different sensing algorithms and programming options.
OBJECTIVE: To describe the management of IASs in patients with an S-ICD.
METHODS: Patients were implanted with an S-ICD between February 2009 and July 2012. The prevalence data and clinical determinants of IASs were prospectively collected. In the case of T-wave oversensing (TWOS), an exercise test was performed, and all possible sensing vectors were screened for TWOS. The absence of TWOS defined a suitable vector.
RESULTS: Eleven of 69 patients (54% men; mean age 39 ± 14 years; 73% primary prevention) received IASs after 8.9 ± 10 months of implantation (10.8% annual incidence rate). In 8 cases, TWOS caused IASs. Seven of these IASs occurred during exercise and 1 during atrial fibrillation with a high ventricular rate. To manage TWOS, in 7 of 8 patients the sensing vector was changed and in 5 of 8 patients the (un)conditional zone was changed. Hereafter, IASs recurred in 3 of 8 patients, in 2 because of programming errors. Hence, after reprogramming, we observed no IASs in 87.5% of the patients with TWOS during a follow-up of 14.1 ± 13 months.
CONCLUSIONS: IASs due to TWOS in the S-ICD can be managed by reprogramming the sensing vector and/or the therapy zones of the device using a template acquired during exercise. Exercise-optimized programming can reduce future IASs, and standard exercise testing shortly after the implantation of an S-ICD may be considered in patients at an increased risk for TWOS.
Copyright © 2014 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ICD programming; ICD sensing; Implantable cardioverter-defibrillator; Inappropriate shocks; Subcutaneous ICD; T-wave oversensing

Mesh:

Year:  2013        PMID: 24321235     DOI: 10.1016/j.hrthm.2013.12.007

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  30 in total

1.  The Entirely Subcutaneous Defibrillator - A New Generation and Future Expectations.

Authors:  Hussam Ali; Pierpaolo Lupo; Riccardo Cappato
Journal:  Arrhythm Electrophysiol Rev       Date:  2015-08

Review 2.  Subcutaneous implantable cardiac defibrillators: indications and limitations.

Authors:  Maria Grazia Bongiorni; Stefano Viani; Giulio Zucchelli; Andrea Di Cori; Luca Segreti; Luca Paperini; Dianora Levorato; Adriano Boem; Giulia Branchitta; Diana Andreini; Ezio Soldati
Journal:  Curr Heart Fail Rep       Date:  2015-02

Review 3.  The subcutaneous ICD-current evidence and challenges.

Authors:  Kiran Haresh Kumar Patel; Pier D Lambiase
Journal:  Cardiovasc Diagn Ther       Date:  2014-12

4.  Conventional and right-sided screening for subcutaneous ICD in a population with congenital heart disease at high risk of sudden cardiac death.

Authors:  Pau Alonso; Joaquín Osca; Joaquín Rueda; Oscar Cano; Pedro Pimenta; Ana Andres; María José Sancho; Luis Martinez
Journal:  Ann Noninvasive Electrocardiol       Date:  2017-05-15       Impact factor: 1.468

5.  The "Pain wave": P‑wave oversensing in subcutaneous ICD.

Authors:  Badder Kattih; David Duncker; Thorben König; Stephan Hohmann; Hanno Oswald; Christian Veltmann
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2016-04-15

Review 6.  [Management of inappropriate shocks/T-wave-oversensing in S-ICD®-patients].

Authors:  Robert Larbig; Markus Bettin; Lukas J Motloch; Alicia Fischer; Niklas Bode; Gerrit Frommeyer; Florian Reinke; Andreas Loeher; Lars Eckardt; Julia Köbe
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2018-02-12

7.  Analysis of Screening Electrocardiogram for the Subcutaneous Defibrillator in Adults with Congenital Heart Disease.

Authors:  Vincent C Thomas; Mark Peterson; Martin McDaniel; Humberto Restrepo; Abraham Rothman; Amit Jain
Journal:  Pediatr Cardiol       Date:  2017-05-22       Impact factor: 1.655

Review 8.  Clinical experience with subcutaneous implantable cardioverter-defibrillators.

Authors:  Geoffrey F Lewis; Michael R Gold
Journal:  Nat Rev Cardiol       Date:  2015-04-21       Impact factor: 32.419

9.  Impact of electrocardiogram screening during drug challenge test for the prediction of T-wave oversensing by a subcutaneous implantable cardioverter defibrillator in patients with Brugada syndrome.

Authors:  Tsukasa Kamakura; Mitsuru Wada; Kohei Ishibashi; Yuko Y Inoue; Koji Miyamoto; Hideo Okamura; Satoshi Nagase; Takashi Noda; Takeshi Aiba; Satoshi Yasuda; Kengo Kusano
Journal:  Heart Vessels       Date:  2017-05-18       Impact factor: 2.037

10.  The Emerging Roles of Leadless Devices.

Authors:  Jeffrey Arkles; Joshua Cooper
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.